
Contact us
About company
VitaLeech Bioscience N.V. develops a recombinant enzyme for the treatment of periodontitis, a form of inflammation of the gum that may result in the loss of teeth. The company engages in the development of recombinant protease inhibitor.
Unknown
Unknown
Unknown
Not verified company